BUZZ · Exit · 1d
weight 0.380% → 0 (exited)·stock up 2.4% in the 30 days before
Jul 16·entry $53.59·now $41.55
Tempus AI Inc
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses.
Close · 3M
-20.58%
None of the tracked AI ETFs currently hold this name.
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
BUZZ · Exit · 1d
weight 0.380% → 0 (exited)·stock up 2.4% in the 30 days before
Jul 16·entry $53.59·now $41.55
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.